Hepatosplenomegaly is associated with low regulatory and Th2 responses to schistosome antigens in childhood schistosomiasis and malaria coinfection

Infection and Immunity

Volumn 76, Issue 5, 2008, Pages 2212-2218

  Wilson, Shona ^a   Jones, Frances M ^a   Mwatha, Joseph K ^b   Kimani, Gachuhi ^b   Booth, Mark ^a   Kariuki, H Curtis ^c   Vennervald, Birgitte J ^d   Ouma, John H ^e   Muchiri, Eric ^c   Dunne, David W ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^c MINISTRY OF HEALTH   (Kenya)

^d DANISH BILHARZIASIS LABORATORY   (Denmark)

^e MASENO UNIVERSITY   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; PARASITE ANTIGEN; SCHISTOSOMA MANSONI SOLUBLE EGG ANTIGEN; SCHISTOSOMA MANSONI SOLUBLE WORM ANTIGEN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; PROTOZOAL DNA;

ADOLESCENT; ARTICLE; BLOOD CULTURE; CELLULAR IMMUNITY; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE EXACERBATION; FEMALE; HEPATOSPLENOMEGALY; HUMAN; IMMUNOREGULATION; KENYA; MAJOR CLINICAL STUDY; MALARIA; MALE; MIXED INFECTION; PARASITE TRANSMISSION; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SCHISTOSOMA; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; TH2 CELL; ANIMAL; BIOSYNTHESIS; BLOOD; CELL CULTURE; HEPATOMEGALY; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALARIA FALCIPARUM; MONONUCLEAR CELL; PARASITEMIA; PARASITOLOGY; PATHOLOGY; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; SPLENOMEGALY;

ADOLESCENT; ANIMALS; ANTIGENS, PROTOZOAN; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; CYTOKINES; DNA, PROTOZOAN; HEPATOMEGALY; HUMANS; KENYA; LEUKOCYTES, MONONUCLEAR; MALARIA, FALCIPARUM; PARASITEMIA; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SPLENOMEGALY; TH2 CELLS;

EID: 42949123132     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.01433-07     Document Type: Article

References (48)

1. Abdel-Wahab, M. F., K. G. Powers, S. S. Mahmoud, and W. C. Good. 1974. Suppression of schistosome granuloma formation by malaria in mice. Am. J. Trop. Med. Hyg. 23:915-918.
2. Aderka, D., J. M. Le, and J. Vilcek. 1989. IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. J. Immunol. 143:3517-3523.
3. Blom, G. 1958. Statistical estimates and transformed beta-variables. Wiley, New York, NY.
4. Boisier, P., C. E. Ramarokoto, P. Ravoniarimbinina, L. Rabarijaona, and V. E. Ravaoalimalala. 2001. Geographic differences in hepatosplenic complications of schistosomiasis mansoni and explanatory factors of morbidity. Trop. Med. Int. Health 6:699-706.
5. Booth, M., B. J. Vennervald, L. Kenty, et al. 2004. Micro-geographical variation in exposure to Schistosoma mansoni and malaria, and exacerbation of splenomegaly in Kenyan school-aged children. BMC Infect. Dis. 4:13.
6. Booth, M., B. J. Vennervald, N. B. Kabatereine, et al. 2004. Hepatosplenic morbidity in two neighbouring communities in Uganda with high levels of Schistosoma mansoni infection but very different durations of residence. Trans. R. Soc. Trop. Med. Hyg. 98:125-136.
7. Colley, D. G., A. A. Garcia, J. R. Lambertucci, et al. 1986. Immune responses during human schistosomiasis. XII. Differential responsiveness in patients with hepatosplenic disease. Am. J. Trop. Med. Hyg. 35:793-802.
8. Corbett, E. L., A. E. Butterworth, A. J. Fulford, J. H. Ouma, and R. F. Sturrock. 1992. Nutritional status of children with schistosomiasis mansoni in two different areas of Machakos District, Kenya. Trans. R. Soc. Trop. Med. Hyg. 86:266-273.
9. Couissinier-Paris, P., and A. J. Dessein. 1995. Schistosoma-specific helper T cell clones from subjects resistant to infection by Schistosoma mansoni are Th0/2. Eur. J. Immunol. 25:2295-2302.
10. Coutinho, H. M., S. T. McGarvey, L. P. Acosta, et al. 2005. Nutritional status and serum cytokine profiles in children, adolescents, and young adults with Schistosoma japonicum-associated hepatic fibrosis, in Leyte, Philippines. J. Infect. Dis. 192:528-536.
11. Diallo, T. O., F. Remoue, A. M. Schacht, et al. 2004. Schistosomiasis co-infection in humans influences inflammatory markers in uncomplicated Plasmodium falciparum malaria. Parasite Immunol. 26:365-369.
12. Dunne, D. W., and E. J. Pearce. 1999. Immunology of hepatosplenic schistosomiasis mansoni: a human perspective. Microbes Infect. 1:553-560.
13. Fallon, P. G., P. Smith, and D. W. Dunne. 1998. Type 1 and type 2 cytokine-producing mouse CD4+ and CD8+ T cells in acute Schistosoma mansoni infection. Eur. J. Immunol. 28:1408-1416.
14. Fulford, A. J., G. G. Mbugua, J. H. Ouma, H. C. Kariuki, R. F. Sturrock, and A. E. Butterworth. 1991. Differences in the rate of hepatosplenomegaly due to Schistosoma mansoni infection between two areas in Machakos District, Kenya. Trans. R. Soc. Trop. Med. Hyg. 85:481-488.
15. Gryseels, B., and A. M. Polderman. 1987. The morbidity of schistosomiasis mansoni in Maniema (Zaire). Trans. R. Soc. Trop. Med. Hyg. 81:202-209.
16. Guadagnoli, E., and W. F. Velicer. 1988. Relation of sample size to the stability of component patterns. Psychol. Bull. 103:265-275.
17. Helmby, H., M. Kullberg, and M. Troye-Blomberg. 1998. Altered immune responses in mice with concomitant Schistosoma mansoni and Plasmodium chabaudi infections. Infect. Immun. 66:5167-5174.
18. Homeida, M., S. Ahmed, A. Dafalla, et al. 1988. Morbidity associated with Schistosoma mansoni infection as determined by ultrasound: a study in Gezira, Sudan. Am. J. Trop. Med. Hyg. 39:196-201.
19. Iwasaki, A., and R. Medzhitov. 2004. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5:987-995.
20. Joseph, S., F. M. Jones, G. Kimani, et al. 2004. Cytokine production in whole blood cultures from a fishing community in an area of high endemicity for Schistosoma mansoni in Uganda: the differential effect of parasite worm and egg antigens. Infect. Immun. 72:728-734.
21. Katz, N. A., A. Chaves, and J. Pellegrino. 1972. A simple device for quantitative stool thick smear technique in schistosomiasis mansoni. Rev. Inst. Med. Trop. Sao Paulo 14:397-400.
22. Kawaguchi, M., M. Adachi, N. Oda, F. Kokubu, and S. K. Huang. 2004. IL-17 cytokine family. J. Allergy Clin. Immunol. 114:1265-1274.
23. Kinyanjui, S. M., D. J. Conway, D. E. Lanar, and K. Marsh. 2007. IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life. Malar. J. 6:82.
24. La Flamme, A. C., A. S. MacDonald, and E. J. Pearce. 2000. Role of IL-6 in directing the initial immune response to schistosome eggs. J. Immunol. 164:2419-2426.
25. Mohamed-Ali, Q., N. E. Elwali, A. A. Abdelhameed, et al. 1999. Susceptibility to periportal (Symmers) fibrosis in human Schistosoma mansoni infections: evidence that intensity and duration of infection, gender, and inherited factors are critical in disease progression. J. Infect. Dis. 180:1298-1306.
26. Mwatha, J. K., G. Kimani, T. Kamau, et al. 1998. High levels of TNF, soluble TNF receptors, soluble ICAM-1, and IFN-gamma, but low levels of IL-5, are associated with hepatosplenic disease in human schistosomiasis mansoni. J. Immunol. 160:1992-1999.
27. Mwatha, J. K., F. M. Jones, G. Mohamed, et al. 2003. Associations between anti-Schistosoma mansoni and anti-Plasmodium falciparum antibody responses and hepatosplenomegaly, in Kenyan schoolchildren. J. Infect. Dis. 187:1337-1341.
28. Omer, F. M., J. A. Kurtzhals, and E. M. Riley. 2000. Maintaining the immunological balance in parasitic infections: a role for TGF-beta? Parasitol. Today 16:18-23.
29. Ongom, V. L., and D. J. Bradley. 1972. The epidemiology and consequences of Schistosoma mansoni infection in West Nile, Uganda. I. Field studies of a community at Panyagoro. Trans. R. Soc. Trop. Med. Hyg. 66:835-851.
30. Pearce, E. J., and A. S. MacDonald. 2002. The immunobiology of schistosomiasis. Nat. Rev. Immunol. 2:499-511.
31. Reimert, C. M., C. M. Fitzsimmons, S. Joseph, et al. 2006. Eosinophil activity in Schistosoma mansoni infections in vivo and in vitro in relation to plasma cytokine profile pre- and posttreatment with praziquantel. Clin. Vaccine Immunol. 13:584-593.
32. Remoue, F., T. O. Diallo, V. Angeli, et al. 2003. Malaria infection in children influences antibody response to schistosome antigens and inflammatory markers associated with morbidity. Trans. R. Soc. Trop. Med. Hyg. 97:361-364.
33. Richter, J., C. Hatz, G. Campagne, N. R. Berquist, and J. M. Jenkins. 2000. Ultrasound in schistosomiasis: a practical guide to the standardized use of ultrasonography for the assessment of schistosomiasis- related morbidity, TDR/STR/SCH/00.1. World Health Organization, Geneva, Switzerland.
34. Roberts, M., A. E. Butterworth, G. Kimani, et al. 1993. Immunity after treatment of human schistosomiasis: association between cellular responses and resistance to reinfection. Infect. Immun. 61:4984-4993.
35. Romagnani, S. 1997. The Th1/Th2 paradigm. Immunol. Today 18:263-266.
36. Rutitzky, L. I., J. R. Lopes da Rosa, and M. J. Stadecker. 2005. Severe CD4 T cell-mediated immunopathology in murine schistosomiasis is dependent on IL-12p40 and correlates with high levels of IL-17. J. Immunol. 175:3920-3926.
37. Singh, B., A. Bobogare, Cox-Singh J., G. Snounou, M. S. Abdullah, and H. A. Rahman. 1999. A genus- and species-specific nested polymerase chain reaction malaria detection assay for epidemiologic studies. Am. J. Trop. Med. Hyg. 60:687-692.
38. Smith, D. H., K. S. Warren, and A. A. Mahmoud. 1979. Morbidity in schistosomiasis mansoni in relation to intensity of infection: study of a community in Kisumu, Kenya. Am. J. Trop. Med. Hyg. 28:220-229.
39. Struik, S. S., and E. M. Riley. 2004. Does malaria suffer from lack of memory? Immunol. Rev. 201:268-290.
40. Urban, B. C., T. T. Hien, N. P. Day, et al. 2005. Fatal Plasmodium falciparum malaria causes specific patterns of splenic architectural disorganization. Infect. Immun. 73:1986-1994.
41. Vennervald, B. J., L. Kenty, A. E. Butterworth, et al. 2004. Detailed clinical and ultrasound examination of children and adolescents in a Schistosoma mansoni endemic area in Kenya: hepatosplenic disease in the absence of portal fibrosis. Trop. Med. Int. Health 9:461-470.
42. Walters, J. H., and I. A. McGregor. 1960. The mechanism of malarial hepatomegaly and its relationship to hepatic fibrosis. Trans. R. Soc. Trop. Med. Hyg. 54:135-145.
43. Whittle, H., M. Gelfand, E. Sampson, A. Purvis, and M. Weber. 1969. Enlarged livers and spleens in an area endemic for malaria and schistosomiasis. Trans. R. Soc. Trop. Med. Hyg. 63:353-361.
44. Williams, M. E., S. Montenegro, A. L. Domingues, et al. 1994. Leukocytes of patients with Schistosoma mansoni respond with a Th2 pattern of cytokine production to mitogen or egg antigens but with a Th0 pattern to worm antigens. J. Infect. Dis. 170:946-954.
45. Williams, M. E., P. Caspar, I. Oswald, et al. 1995. Vaccination routes that fail to elicit protective immunity against Schistosoma mansoni induce the production of TGF-beta, which down-regulates macrophage antiparasitic activity. J. Immunol. 154:4693-4700.
46. Wilson, S., B. J. Vennervald, H. Kadzo, et al. 2007. Hepatosplenomegaly in Kenyan schoolchildren: exacerbation by concurrent chronic exposure to malaria and Schistosoma mansoni infection. Trop. Med. Int. Health 12:1442-1449.
47. Wilson, S., M. Booth, F. M. Jones, et al. 2007. Age-adjusted Plasmodium falciparum antibody levels in school-aged children are a stable marker of microgeographical variations in exposure to Plasmodium infection. BMC Infect. Dis. 7:67.
48. Yoshida, A., H. Maruyama, T. Kumagai, et al. 2000. Schistosoma mansoni infection cancels the susceptibility to Plasmodium chabaudi through induction of type 1 immune responses in A/J mice. Int. Immunol. 12:1117-1125.